Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
kr34.98 Mil
% of Total Estimate Gain
50.84%

SA Fidelity Institutional AM International Growth Portfolio's Novo Nordisk AS Holding Summary

As of 2025-04-30, SUNAMERICA SERIES TRUST held - shares of Novo Nordisk AS(OCSE:NOVO B), totaling N/A. This investment constitutes 0% of their stock portfolio, and SUNAMERICA SERIES TRUST now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2020Q1. And since then SA Fidelity Institutional AM International Growth Portfolio has made 8 purchases of OCSE:NOVO B, at an average price of kr239.17, for a total of 287,640.00 shares. In addition, there have been 12 sales at an average price of kr360.78 for 287,640.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr423.90, SA Fidelity Institutional AM International Growth Portfolio's estimated gain on his OCSE:NOVO B holdings is kr34.98 Mil, reflecting a 50.84% gain to date.

SA Fidelity Institutional AM International Growth Portfolio OCSE:NOVO B (kr423.90) Holding Chart

SA Fidelity Institutional AM International Growth Portfolio OCSE:NOVO B (kr423.90) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1